High-frequency rTMS over bilateral primary motor cortex improves freezing of gait and emotion regulation in patients with Parkinson's disease: a randomized controlled trial.

Authors:
Song W; Zhang Z; Lv B; Li J; Chen H and 19 more

Journal:
Front Aging Neurosci

Publication Year: 2024

DOI:
10.3389/fnagi.2024.1354455

PMCID:
PMC10847258

PMID:
38327498

Journal Information

Full Title: Front Aging Neurosci

Abbreviation: Front Aging Neurosci

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Geriatrics & Gerontology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This publication was supported by the R&D Program (Social Development) of Jiangsu Province (BE2021630), the Key R&D Program (Social Development) of Xuzhou (KC22249), and the Key R&D Program (Social Development) of Suqian (S202203)."

Evidence found in paper:

"(i) Subjective decision: according to item 3 of the Freezing of Gait Questionnaire (FOGQ) (; ), patients were asked whether they felt their feet were stuck to the ground during starting, turning, or walking; (ii) subjective determination: confirmed by showing typical videos of a typical freezing gait episode to the patient and caregivers (); (iii) Objective determination: freezing gait was induced by bi-directional 360° rapid turns, dual-tasking, and small rapid steps (; ); (d) Hoehn-Yahr stage (H-Y stage) (; ): stage 2–4; (e) Mini-Mental State Examination (MMSE) () ≥ 24 points; (f) PD medication stabilized for more than 2 weeks and no change in medication regimen during the study period; and (g) being available to cooperate in completing the rTMS treatment and symptom assessment. The study protocol was approved and supervised by the Affiliated Hospital of Xuzhou Medical University Ethics Committee (No. XYFY2019-KL205-02). All patients had agreed and confirmed their informed consent prior to the study. The present study was registered at the Chinese Clinical Trial Registry (Registration number: ChiCTR2000031717)."

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025